Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)

4.60
Delayed Data
As of Dec 08
 -0.15 / -3.16%
Today’s Change
3.50
Today|||52-Week Range
10.36
-36.11%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Roberts Richard John
Director
Buy8/19/201670,000$0.29$20.3K-38.50%
Roberts Richard John
Director
Buy2/10/201635,000$0.29$10.2K+25.68%
Joseph Tamara Lynn
General Counsel & Senior Vice President
Gift12/31/20151,599$6.12$9.8K-36.11%
Perrin Mark D
Chief Executive Officer
Gift12/31/20151,053$6.12$6.4K-36.11%
Roberts Richard John
Director
Buy12/29/201520,000$0.29$5.8K-36.55%
Masuoka Lorianne K
Chief Medical Officer
Gift12/31/2015265$6.12$1.6K-36.11%
Ulich Thomas R
Chief Scientific Officer
Gift12/31/2015265$6.12$1.6K-36.11%
Mcallister Steven F
Chief Financial Officer
Gift12/31/2015232$6.12$1.4K-36.11%